Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities

Transl Oncol. 2022 Dec:26:101510. doi: 10.1016/j.tranon.2022.101510. Epub 2022 Sep 16.

Abstract

Several different signaling pathways and molecular mechanisms have been identified as responsible for controlling critical functions in human cancer cells, such as selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasis, metabolic rewiring, an abetting microenvironment, and immune modulation. This concise summary will provide a selective review of recent studies of key signal transduction pathways, including mitogen-activated protein kinase (MAPK) pathway, Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling, and Wnt/β-catenin signaling pathway, which are altered in cancer cells, as the novel and promising therapeutic targets.

Keywords: MAPK; PI3K/AKT/mTOR; Signaling pathways; Therapeutic opportunities; Wnt/β-catenin.